\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes AI ContinentThe European Commission has published a new call (one call topic) under the Digital Europe programme: Alliance for Language Technologies (DIGITAL-2024-AI-B-06-LANGUAGE).
The call is expected to open on 1 August 2024, deadline to submit proposals will be 26 September 2024.
With this call, the Commission aims to federate Member States efforts to preserve the linguistic and cultural diversity in Europe while effectively implementing the European Common Data Infrastructure and Service MCP’s objectives in the area of language technologies. By providing the necessary data and model adaptation capacities, the action will have a strong impact on the deployment of large language foundation models and their applications such as generative AI.
The relevant information on objectives, scope and conditions of participation can be found in the call document.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
